Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Switching from TDF to TAF was associated with a less favorable blood fat profile.
As with HIV-negative individuals, non-alcoholic fatty liver disease is tied to diabetes and irregular blood lipids in those with HIV.
Researchers sought to model the future rates of conditions such as chronic kidney disease and high blood pressure among people with HIV.
Among people with well-treated HIV, age-associated non-AIDS-related health conditions are increasing.
Compared with their HIV-negative peers, HIV-positive individuals have higher rates of treatment for a host of health problems.
The condition is a manifestation of cardiovascular disease.
A small study of Spanish people with HIV taking Prezista (darunavir) found that cholesterol and triglycerides dropped after the switch.
Cutting standard dose of Kaletra by 30 percent does not change its efficacy at suppressing HIV and it improves lipid levels among children.
For some people, living with HIV can mean working extra hard to have a healthy heart.
Lipitor (atorvastatin) and Crestor (rosuvastatin)—two drugs in the statin family—were about twice as likely as the statin Pravacho...
Another risk factor for peripheral neuropathy among people living with HIV has been identified by researchers: elevated triglyceride levels. A...
People on a regimen containing efavirenz (found in Sustiva and Atripla) who have neurological side effects or abnormal cholesterol or triglyce...
People on a regimen containing abacavir saw their cholesterol drop quickly and significantly when they switched to a similar regimen containin...
Replacing Norvir boosted protease inhibitor with Isentress may be an option with improvements in blood lipid levels for HIV-positive
Switching from Kaletra (lopinavir plus ritonavir) to Isentress (raltegravir) when viral load is undetectable might help reduce elevated choles...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.